Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CYP2D6”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02940379
What this trial is testing

A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 24
Not applicableStudy completedNCT05463003
What this trial is testing

Impact of OCT1 and CYP2D6 Genotypes on Pharmacokinetics of Berberine in Healthy Volunteers

Who this might be right for
Pharmacokinetic Study in Healthy Volunteers
University Medicine Greifswald 42
Not applicableStudy completedNCT00783783
What this trial is testing

CYP2D6 Pharmacogenetics in Risperidone-Treated Children

Who this might be right for
Psychiatric DisordersNeurodevelopmental Disorders
Children's Hospital Medical Center, Cincinnati 47
Early research (Phase 1)Study completedNCT01187862
What this trial is testing

Pharmacokinetic Study to Investigate Low-dose Combinations of a Cocktail of Seven Drugs for Simultaneous Phenotyping of Cytochromes

Who this might be right for
CytochromePharmacokinetics
University Hospital, Basel, Switzerland 16
Not applicableUnknownNCT01503645
What this trial is testing

Chinese Herb Nephropathy Epidemiology and Association With CYP2D6, CYP2C19, PXR, or MDR1 Polymorphism

Who this might be right for
Kidney Diseases
National Taiwan University Hospital 200
Not applicableStudy completedNCT02335307
What this trial is testing

Implementing Genomics in Practice (IGNITE) Proof of Concept Study: Genotyping in Family Medicine Clinics

Who this might be right for
Pain
University of Florida 505
Not applicableUnknownNCT00945867
What this trial is testing

Cytochrome P450 2D6 (CYP 450 2D6) Genotype and Flecainide Efficacy

Who this might be right for
Atrial Fibrillation
Assaf-Harofeh Medical Center 100
Not applicableStudy completedNCT04188028
What this trial is testing

Endobiotics for Phenotyping of Human Cytochrome P450 Enzymes

Who this might be right for
Healthy
Jules Desmeules 40
Large-scale testing (Phase 3)Study completedNCT00329186
What this trial is testing

Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 14
Not applicableUnknownNCT03504631
What this trial is testing

Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on Tamoxifen

Who this might be right for
Breast Cancer Female
Trisakti University 117
Not applicableStudy completedNCT05966142
What this trial is testing

A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Chronic Pain Trial)

Who this might be right for
Chronic Pain
Duke University 1,048
Early research (Phase 1)Looking for participantsNCT06383338
What this trial is testing

A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.

Who this might be right for
Hodgkin LymphomaNon Hodgkin Lymphoma
Murdoch Childrens Research Institute 10
Early research (Phase 1)Study completedNCT02225093
What this trial is testing

Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan in Men With Prostate Cancer

Who this might be right for
Pharmacokinetics of DextromethorphanPharmacokinetics of CaffeineProstate Cancer
Astellas Pharma Europe B.V. 12
Not applicableNot Yet RecruitingNCT07817030
What this trial is testing

Evaluation of Solanidine as an Exogenous Biomarker to Phenotype CYP2D6 Activity in Humans

Who this might be right for
Pharmacokinetic Study in Healthy Volunteers
University Medicine Greifswald 30
Early research (Phase 1)Looking for participantsNCT07204418
What this trial is testing

Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants

Who this might be right for
Healthy Volunteers
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 56
Early research (Phase 1)Study completedNCT06232109
What this trial is testing

Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects

Who this might be right for
Drug Drug Interaction
Asceneuron S.A. 50
Early research (Phase 1)Study completedNCT01192308
What this trial is testing

PharmacoKINEtics of TAMoxifen and Its Metabolites in Breast Cancer Patients: the Influence of a Dose Increase in Phenotypic Poor Metabolizers of CYP2D6 (KINETAM)

Who this might be right for
Breast Cancer
Radboud University Medical Center 42
Not applicableStudy completedNCT00900744
What this trial is testing

A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6

Who this might be right for
Breast Cancer
Icahn School of Medicine at Mount Sinai 121
Not applicableStudy completedNCT03114098
What this trial is testing

Pharmacogenetics Anomaly Research in Children and Adolescents With Pharmacological Resistance to Psychotropic Drugs

Who this might be right for
Drug ResistancePsychotropic Drugs
Fondation Lenval 22
Early research (Phase 1)Study completedNCT03716427
What this trial is testing

Drug Interaction Study of CT1812 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Cognition Therapeutics 16
Next Page